Skip to main content
Premium Trial:

Request an Annual Quote

IBM, Adobe Among First Six Vendors to Join SAFE-BioPharma Electronic Signature Initiative

NEW YORK, Dec. 30 (GenomeWeb News) - Six technology companies will develop software and applications for the pharmaceutical and healthcare industries using a digital signature standard developed by the SAFE-BioPharma Association, the organization said today.


The SAFE (Secure Access for Everyone) Vendor Partner Program encourages development of business applications, infrastructure, services and identity credentials, the association said. SAFE-BioPharma will test each application to guarantee it conforms to SAFE requirements.


Adobe, Arcot Systems, CoreStreet, nCipher, IBM, and Kyberpass are the first members of the program.


SAFE is expected to reduce medical research and drug development costs. The National Cancer Institute, US Food and Drug Administration, and the European Medicines Agency have committed to adopting the SAFE standard, the organization said.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.